Literature DB >> 27077381

Small Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in Cirrhotic Livers May Share Similar Enhancement Patterns at Multiphase Dynamic MR Imaging.

Bin Huang1, Lu Wu1, Xin-Yuan Lu1, Feng Xu1, Cai-Feng Liu1, Wei-Feng Shen1, Ning-Yang Jia1, Hong-Yan Cheng1, Ye-Fa Yang1, Feng Shen1.   

Abstract

Purpose To assess the accuracy of magnetic resonance (MR) imaging-based differential diagnosis of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) in a cohort of patients with focal liver lesions and cirrhosis. Materials and Methods This study was institutional review board approved, and the requirement for informed consent was waived. Between January 2009 and December 2014, a cohort of cirrhotic patients, including 71 with ICC and 612 with HCC, underwent unenhanced T1- and T2-weighted MR imaging, gadolinium-based contrast material-enhanced dynamic phase imaging, and partial hepatectomy. Results of pathologic examinations were obtained for all patients. Clinical, radiologic, and pathologic results in these patients were analyzed and compared comprehensively. Differences in signal intensity on baseline and contrast material-enhanced images and dynamic enhancement patterns were evaluated and compared by using the χ(2) test or the Fisher exact test. Results The preoperative diagnoses of 517 of 683 lesions were confirmed pathologically. Five ICCs and 481 HCCs displayed contrast material washout in delayed phases (P < .001). Thirty-six ICCs and 23 HCCs displayed a progressive enhancement pattern (P < .001). Twenty-six ICCs and 63 HCCs displayed a stable enhancement pattern (P < .001). ICCs displayed significantly different enhancement patterns according to size (P = .022). Conclusion The accurate discrimination of small ICCs from HCCs in the setting of cirrhosis at MR imaging is difficult, as substantial proportions of ICCs and HCCs have similar enhancement patterns. Absence of contrast material washout at MR imaging is not a factor that prevents the misdiagnosis of HCC. (©) RSNA, 2016 Online supplemental material is available for this article.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27077381     DOI: 10.1148/radiol.2016151205

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  26 in total

1.  Different MR features for differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma according to tumor size.

Authors:  Ting Ni; Xiao-Sha Shang; Wen-Tao Wang; Xin-Xing Hu; Meng-Su Zeng; Sheng-Xiang Rao
Journal:  Br J Radiol       Date:  2018-06-05       Impact factor: 3.039

2.  Liver Imaging Reporting and Data System on CT and gadoxetic acid-enhanced MRI with diffusion-weighted imaging.

Authors:  Dong Ik Cha; Kyung Mi Jang; Seong Hyun Kim; Tae Wook Kang; Kyoung Doo Song
Journal:  Eur Radiol       Date:  2017-04-03       Impact factor: 5.315

Review 3.  Hepatic nodules with arterial phase hyperenhancement and washout on enhanced computed tomography/magnetic resonance imaging: how to avoid pitfalls.

Authors:  Mimi Tang; Yin Li; Zhi Lin; Bingqi Shen; Mengqi Huang; Zi-Ping Li; Xuehua Li; Shi-Ting Feng
Journal:  Abdom Radiol (NY)       Date:  2020-11

Review 4.  Problematic lesions in cirrhotic liver mimicking hepatocellular carcinoma.

Authors:  Myeong-Jin Kim; Sunyoung Lee; Chansik An
Journal:  Eur Radiol       Date:  2019-02-20       Impact factor: 5.315

5.  Liver biopsy technique in the era of genomic cancer therapies: a single-center retrospective analysis.

Authors:  Yusuke Ozeki; Naoya Kanogawa; Sadahisa Ogasawara; Keita Ogawa; Takamasa Ishino; Miyuki Nakagawa; Kisako Fujiwara; Hidemi Unozawa; Terunao Iwanaga; Takafumi Sakuma; Naoto Fujita; Ryuta Kojima; Hiroaki Kanzaki; Keisuke Koroki; Kazufumi Kobayashi; Masato Nakamura; Soichiro Kiyono; Takayuki Kondo; Tomoko Saito; Ryo Nakagawa; Eiichiro Suzuki; Yoshihiko Ooka; Shingo Nakamoto; Ryosuke Muroyama; Akinobu Tawada; Tetsuhiro Chiba; Makoto Arai; Jun Kato; Jun-Ichiro Ikeda; Yuichi Takiguchi; Naoya Kato
Journal:  Int J Clin Oncol       Date:  2022-06-15       Impact factor: 3.850

6.  Liver Cancer Study Group of Japan Clinical Practice Guidelines for Intrahepatic Cholangiocarcinoma.

Authors:  Shoji Kubo; Hiroji Shinkawa; Yoshinari Asaoka; Tatsuya Ioka; Hiroshi Igaki; Namiki Izumi; Takao Itoi; Michiaki Unno; Masayuki Ohtsuka; Takuji Okusaka; Masumi Kadoya; Masatoshi Kudo; Takashi Kumada; Norihiro Kokudo; Michiie Sakamoto; Yoshihiro Sakamoto; Hideyuki Sakurai; Tadatoshi Takayama; Osamu Nakashima; Yasushi Nagata; Etsuro Hatano; Kenichi Harada; Takamichi Murakami; Masakazu Yamamoto
Journal:  Liver Cancer       Date:  2022-02-23       Impact factor: 12.430

7.  Imaging features of hepatocellular carcinoma compared to intrahepatic cholangiocarcinoma and combined tumor on MRI using liver imaging and data system (LI-RADS) version 2014.

Authors:  Natally Horvat; Ines Nikolovski; Niamh Long; Scott Gerst; Jian Zheng; Linda Ma Pak; Amber Simpson; Junting Zheng; Marinela Capanu; William R Jarnagin; Lorenzo Mannelli; Richard Kinh Gian Do
Journal:  Abdom Radiol (NY)       Date:  2018-01

8.  Diagnostic performance of the LR-M criteria and spectrum of LI-RADS imaging features among primary hepatic carcinomas.

Authors:  Seung-Seob Kim; Sunyoung Lee; Jin-Young Choi; Joon Seok Lim; Mi-Suk Park; Myeong-Jin Kim
Journal:  Abdom Radiol (NY)       Date:  2020-11

9.  Small masses (≤3 cm) diagnosed as hepatocellular carcinoma on pre-treatment imaging: comparison of therapeutic outcomes between hepatic resection and radiofrequency ablation.

Authors:  Dong Ik Cha; Kyoung Doo Song; Tae Wook Kang; Min Woo Lee; Hyunchul Rhim
Journal:  Br J Radiol       Date:  2019-11-04       Impact factor: 3.039

Review 10.  Cancer and hepatic steatosis.

Authors:  R Paternostro; W Sieghart; M Trauner; M Pinter
Journal:  ESMO Open       Date:  2021-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.